Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Patidegib
Therapeutic Area : Oncology
Study Phase : Phase III
Recipient : PellePharm
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : PellePharm’s patedigib topical gel is an investigational treatment to be used for rare dermatologic conditions. This is the first step in efforts to enable the renewable production of cyclopamine.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 11, 2021
Lead Product(s) : Patidegib
Therapeutic Area : Oncology
Highest Development Status : Phase III
Recipient : PellePharm
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
KEY PRODUCTS
Reset All
Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.